Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)

Martin L. Katz, Joan R. Coates, Christine Toedebusch, Jacob D. Taylor, Melissa Carpentier, Whitney M. Young, Fred A. Wininger, Derek Kennedy, Brian R. Vuillemenot, Charles A. O'Neill

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)'. Together they form a unique fingerprint.

Medicine & Life Sciences